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胞癌13例中，11例が genotype C,2例が genotype A






抗原陰性 Odds比（Cl 95%) P 値
性別
男性 182 114(62.6%) 0.835(0.521-1.339) 0.453
女性 120 70(58.3%)
年齢
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抗原陰性 Odds比（Cl 95%) P 値
性別
男性 182 26(14.3%) 2.889(1.652-5.125) 0.0002
女性 120 39(32.5%)
年齢




B 92 31(33.7%) 0.380(0.215-0.671) 0.0008
C 210 34(16.2%)




A B  C  D  E  F
北ヨーロッパ 24 1 3 12 0 0
南ヨーロッパ 1 0 0 7 0 0
アフリカ 8 0 0 4 3 0
中東 1 0 0 36 0 0
東南アジア 10 30 18 0 0 0
北東アジア 0 1 13 0 0 0
南アメリカ 0 0 0 0 0 1
日本（仙台，本研究) 8 92 210 0 0 0
日本（本研究）以外はLindhらの報告した症例
数を示した。
――American Society of Gene Theraphy:Travel Award――
改変型BAX遺伝子発現アデノウイルスベクターによる遺伝子治療





































































はApaf 1と結合し，Apaf 1/caspsae 9 complexの
東北医誌 114:65-67，2002
形成を促し，complex形成によって活性化された
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ABSTRACT
 
Brain MRI for normal
 










between them or between
 
such findings and cognitive functions have not been
 
fully studied. We investigated the relationships
 
between CC atrophy and the WMH,together with
 
frontal executive dysfunctions in normal aging and
 
AD. We examined 170 randomly selected residents
 
in a community:99 CDR (Clinical Dementia Rat-
ing)-0 (normal control,NC)participants, 54 CDR
 
0.5 (very mild AD) patients, and 17 CDR 1 & 2
(probable AD) patients. Using MRI, the WMH
 
and CC atrophy was visually rated. The MMSE
 
was performed to assess global function. For the
 
frontal function, letter-based fluency, the Digit
 
Symbol test of the WAIS-R,and Trail Making Test
 
were performed. Frontal executive dysfunction
 
was associated with CC atrophy in both NC and AD
 
groups. A combined effect of CC atrophy and
 
WMH on the verbal fluency test was noted in the
 
NC group. In both groups, CC atrophy was as-
sociated with frontal executive dysfunction. A
 
combined effect of CC atrophy and WMH in normal
 





Brain MRI for normal aging and Alzheimer’s
 
disease (AD) frequently reveals corpus callosum
(CC) atrophy and white matter hyperintensity
(WMH) . Since an atrophied CC is considered to
 
indicate neocortical dysfunction related to left
-right asymmetry , it is reasonable that AD
 
patients should show CC atrophy. As for the
 
WMH,AD patients were found to have it as normal
 
older adults. However, the neurological signifi-
cance of WMH in AD is still controversial,and the
 
relationships between CC atrophy and WMH in
 
normal older adults and AD patients have not been
 
fully investigated. We previously found WMH to
 
be correlated with CC atrophy in cerebral is-
chemia . The largest number of neurons project-
ing into the CC is that of large pyramidal cells of
 
cortical layer III;they terminate in layers III-IV of
 
the contralateral hemisphere . Cerebral ischemia
 
may result in damage to the neurons in layer III ,
thus leading to Wallerian degeneration of the CC .
Since WMH is manifested as ischemia in the white
 
matter and since the CC is made of fibers consisting
 
of white matter, cortical ischemia results in CC
 
atrophy by Wallerian degeneration and leads to
 
WMH,not only due to Wallerian degeneration but
東北医誌 114:74-77，2002
 
also as the result of small arteries sclerotic changes.
In AD, however, such a relationship is controver-
sial . A possible interpretation is non-ischemic
 
neuronal loss. WMH and CC atrophy may be
 
markers of cortical neuronal loss. We hypothes-
ized:1)WMH might be correlated with CC atro-
phy in normal adults but not in AD. 2)Frontal
 
executive dysfunctions might be associated with
 
WMH and/or CC atrophy in normal but with only
 
CC atrophy in AD.
METHODS
 
The protocol for selecting the participants was as
 
follows, as previously described . Written
 
informed consent was received from all the NC
 
participants and the family members of the AD
 
group. The midsagittal T1-weighted MRI (0.5T)
image was used for assessment of the CC,combined
 
axial T1-weighted and T2-weighted images were
 
used to evaluate the WMH. Lesions were consid-
ered to be “cerebrovascular diseases”when they
 
showed low intensity on the T1-weighted MRI and
 
high intensity on the T2-weighted MRI at the same
 
location. The lesions were considered to be WMH
 
when they had right-left symmetrical high intensity
 
on the T2-weighted MRI with an isointensity on the
 
T1-weighted MRI, being adjacent to the lateral
 
ventricle. A radiologist rated CC atrophy and the
 
WMH based on a 4-point scale. According to the
 
visual ratings of the CC and the diagnosis, the
 
participants were classified into four groups:NC-
CC (－) group, NC-CC (＋) group, AD-CC (－)
group,and AD-CC(＋)group. Taking into consid-
eration that the smaller number of CDR 1 & 2
 
participants might negatively affect statistical
 
power,we used the CDR 0.5 and CDR 1& 2 groups
 
together as the AD group, since they were consid-
ered to have very mild AD and probable AD,respec-
tively. Table 1 shows the demographics of the
 
groups. The MMSE was performed by neuropsy-
chologists and trained public health nurses,indepen-
dent of CDR assessments,as frontal lobe function
 
tests. For frontal lobe function, letter-based flu-
ency,Digit Symbol test of the WAIS-R,and Trail
 
Making Tests (TMT)-A were performed.
RESULTS
 
Table 2 demonstrates the results. All scores of
 
the AD groups were significantly lower than those
 
of the NC groups, indicating the strong effect of
 
diagnosis. Among the NC groups, the group with
 
greater CC atrophy manifested some frontal impair-
ments,as shown by the verbal fluency test and Digit
 
Symbol test. Among the AD groups, the AD-CC
(＋)group tended to score lower than the AD-CC
(－) and NC-CC (＋) groups on most cognitive
 
tests. As for the Digit Symbol test of the WAIS-R,
the AD-CC(＋)group showed a significantly lower
 
score compared with all other groups. There were
 
significant Spearman’s correlations between the CC
 
atrophy and WMH for the NC and AD groups. For
 
the possible combined effect of CC atrophy and
 
WMH,three-way MANOVA was performed. For
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Table 1. Demographics and the CC measures in
 






CC (－) CC (＋)
AD
 
CC (－) CC (＋)
n  60  32  38  29
 
age  71.4  73.1  73.9  77.5
education  8.2  8.1  7.1  7.4
 
NC＝normal control, AD＝Alzheimer’s disease,
CC＝corpus callosum,CC (＋)＝CC atrophy.




CC (－) CC (＋)
AD
 
CC (－) CC (＋)
Global function
 
MMSE  25.8  26.4  22.7 21.2
Frontal function
 
verbal fluency  7.7  6.1 6.1 4.7
Digit Symbol  28.2  23.4 21.2 15.5
TMT A (sec) 94.7  104.9  149.2 169.6
a,b,c:significantly different from NC CC (－)
group,NC CC(＋)group,AD CC(－)group(p＜
0.05).
NC＝normal control, AD＝Alzheimer’s disease,
CC＝corpus callosum, CC (＋)＝CC atrophy,
MMSE＝Mini Mental Examination, TMT＝Trail
 
Making Test.
the verbal fluency test,there were significant effects
 
of diagnosis and CC atrophy with as interaction of
 
diagnosis,WMH,and CC atrophy. A post hoc test
 
indicated that the NC-WMH (＋)-CC (＋)group
 
had a significantly lower score than that of the NC-
WMH(＋)-CC(－)group. Among the AD groups,





The correlation between CC atrophy and WMH
 
in normal older adults should be discussed first.
Previously,we found a correlation of CC atrophy
 
and WMH in a cognitively normal group with some
 
risk factors . We discussed the fact that risk fac-
tors may be associated with WMH and CC atrophy
 
in the absence of stroke,and consequently,one may
 
argue that ischemia is possibly the mechanism by
 
which risk factors induce such brain changes. We
 
previously demonstrated that in participants with
 
risk factors without overt stroke attack,there were
 
significant correlations between the % stenosis of
 
the ICA and the ipsilateral CaBF (carotid blood
 
flow). There was also a significant relationship
 
between CBF and CaBF in the severe WMH group.
This indicated that such group could have cerebral
 
ischemia,resulting in WMH and CC atrophy being
 
correlated. Although about half of the NC group
 
participants had hypertension, their CaBF or CBF
 
were not measured, nor was angiography perfor-
med. However, the above-mentioned previous
 
findings suggest that some of them might have
 
subclinical ischemia. Regarding AD,we found that
 
CC atrophy and WMH were correlated contrary to
 
the hypothesis. The fact that about half of the AD
 
participants in this study also suffered from hyper-
tension,might have affected the correlation as with
 
the NC group. We found that CC atrophy negative-
ly affected some frontal executive functions in both
 
groups. A combined effect of CC atrophy and
 
WMH on the verbal fluency test was only noted in
 
the NC group. The verbal fluency test in this study
 
is letter-based. Although the AD participants in
 
this study showed the effect of CC atrophy on cate-
gory fluency, on statistical difference was found
 
between the two fluency tasks. A combined effect
 
of CC atrophy and WMH on the verbal fluency test
 
in the NC group should be discussed. The simplest
 
interpretation was that subclinical ischemic partici-
pants showing both CC atrophy and WMH might
 
have affected the test score. Namely,the presence
 
of WMH affected the global decrease of CBF,
decreasing the frontal function, and CC atrophy
 
affected the fluency score.
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言語性 IQ ― 63



















































































































































259 (2000年 9 月，日本失語症学会）に掲載された原著
論文の要約である．
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図 5. 言語性短期記憶の機能モデル（改訂版）．
Vallar & Papagno (1995）の言語性短期記憶の機能モデルを引用したこのモデルでは，意味性短期記憶シ
ステム（意味性短期貯蔵庫）が付加してある．
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ALSに対する新しい治療法の開発
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H46R-4  144.7± 6.4  24.2±2.9
 
H46R-13 ― ―
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1) SLPI遺伝子の発現調節機構（Am J  Respir
 






































伝子上流132 bpから 92 bpまでのDNA配列を用い
て，バンドシフト法を行った．このDNA領域に結合す













図4. (A)ヒトとマウスにおけるSLPI遺伝子の構造 (B)ヒト SLPIの遺伝子座 (C)マウスSLPIの
遺伝子座






















3) マウスSLPI遺伝子の単離同定（Am J Respir
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録し，引き続き2 mA, 10 mA, 20 mA, 30 mAの刺激
および感覚閾刺激と痛覚閾刺激とをランダムに加え，
再び通電量0mAに対する記録を行った．電気刺激前




















15.1±8.4 mA，痛覚閾値は IBS群で 16.6±7.5 mAで
あったのに対し対照群では23.9±6.9 mAであった．と
もに IBS群が有意（p＜0.05）に低い値を示した．
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図 3. 誘発電位（トポグラム）
左 :対照群10名を平均したトポグラム 右 :IBS群 10名を平均したトポグラム
刺激開始100 msec（右下）から380 msec（左上）まで20 msecごとに表示
白 :陽性電位の振幅大，黒 :陰性電位の振幅大
トポグラムの左下の数値 上段 :潜時（msec），下段 :振幅のMAX値
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アレキシサイミアにおける表情認知時の脳血流量変化
PETによる解析
Positron emission tomography revealed the specific brain processing of
 
emotion by facial expressions in alexithymia
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